These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6967603)

  • 1. [T-lymphocyte content in the blood in nephrotuberculosis under antibactertial and immunostimulation therapy].
    Mukanbaev K; Vladimirskiĭ MA
    Probl Tuberk; 1980 Aug; (8):40-2. PubMed ID: 6967603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological status of nephrotuberculosis patients undergoing combined therapy using immunocorrective agents].
    Borisov AV; Skosogorenko MG; Petrovskiĭ BV
    Probl Tuberk; 1985; (4):44-8. PubMed ID: 3873651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI; Pisarevskaia LI; Nikishina EV
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the immunocorrective preparation levamisole in treating renal tuberculosis and posttuberculotic pyelonephritis].
    Mochalova TP; Vladimirskiĭ MA; Mukanbaev K; Braude VI
    Probl Tuberk; 1982 Jun; (6):40-4. PubMed ID: 6981810
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological correction in progressive pulmonary tuberculosis].
    Maslennikov AA; Kamenev VF; Kolomiets VM
    Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunomodulation in patients with cavernous kidney tuberculosis using piperazine adipinate and amniocene].
    Kozin IuI; Cherniavskii VI
    Probl Tuberk; 1991; (6):29-32. PubMed ID: 1780305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sodium nucleinate on immunological and nonspecific responsiveness in elderly and senile patients].
    Adambekov DA; Litvinov VI; Koshmuratov AG; Mambetov KB; Sabyrbekova TS
    Probl Tuberk; 1999; (4):27-30. PubMed ID: 10479929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neutrophilic and lymphocytic factors of an immune response in renal tuberculosis].
    Iagafarova RK; Potapenko EI; Shenderova RI; Iakunova OA; Korolenok OL; Kusursuz MO; Sushkova EA
    Probl Tuberk Bolezn Legk; 2003; (10):27-30. PubMed ID: 14669626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses and immunostimulation in tuberculosis therapy.
    Gatner EM; Anderson R
    S Afr Med J; 1982 May; 61(19):707-10. PubMed ID: 6979105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplenic and transtumoral in vivo immunostimulation: effect on cellular immunity parameters.
    Boura P; Kountouras J; Lygidakis NJ; Safioleas M; Aphinives P
    Hepatogastroenterology; 1999; 46(26):799-803. PubMed ID: 10370616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
    Khomenko AG; Insanov AB
    Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential use of immunostimulants with chronic pneumonia patients].
    Grigor'ev PIa; Karaulov AV; Shul'gin AV; Bulycheva NA; Mal'tsev VI
    Ter Arkh; 1983; 55(3):90-4. PubMed ID: 6602393
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laser therapy in renal tuberculosis: mechanism of action].
    Kul'chavenia EV
    Probl Tuberk; 1995; (2):11-3. PubMed ID: 7777451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
    Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polychemotherapy combined with low-intensity laser therapy in treating patients with renal tuberculosis].
    Kul'chavenia EV
    Urologiia; 2002; (2):34-7. PubMed ID: 12077821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunology of renal tuberculosis and its importance from the therapeutic point of view].
    Strauss I
    Clin Ter; 1971 Nov; 59(3):195-205. PubMed ID: 5160466
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunity of middle age and aged patients with tuberculosis and its changes during multimodality treatment by using T-activin].
    Adambekov DA; Litvinov VI; Mambetov KB; Koshmuratov AG; Sabyrbekova TS
    Probl Tuberk; 1998; (5):46-8. PubMed ID: 9866400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of different immunomodulators on the subpopulations of immunocompetent cells. The immunomodulating therapy of respiratory diseases].
    Sil'vestrov VP; Karaulov AV; Martsinovskiĭ VIu; Likov VF
    Ter Arkh; 1985; 57(1):70-5. PubMed ID: 3872483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.